What is Hofseth BioCare ASA Gross-Profit-to-Asset %?
Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hofseth BioCare ASA's annualizedGross Profit for the quarter that ended in Mar. 2024 was kr100.0 Mil.
Hofseth BioCare ASA's average Total Assets over the quarter that ended in Mar. 2024 was kr390.4 Mil. Therefore, Hofseth BioCare ASA's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 25.63%.
Hofseth BioCare ASA Gross-Profit-to-Asset % Historical Data
The historical data trend for Hofseth BioCare ASA's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hofseth BioCare ASA's Gross-Profit-to-Asset %
For the Biotechnology subindustry, Hofseth BioCare ASA's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hofseth BioCare ASA's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Hofseth BioCare ASA's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Hofseth BioCare ASA's Gross-Profit-to-Asset % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Mar. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Hofseth BioCare ASA Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Hofseth BioCare ASA's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Hofseth BioCare ASA (OSTO:HBCO) Business Description
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:HBCO has been successfully added to your 